by ComplianceQuest
My Dashboard
Inspection Tracker
FDA Guidance
Templates
Assessments
Sign in
Get started
Tracker Overview
Enforcement Themes
Form 483s
Warning Letters
Inspections
Recalls
Investigators
Companies
Facilities
Loading…
Dashboard
Warning Letters
Warning Letter Details
Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital Warning Letter Details
Warning Letter
Watch this company
View Letter
Overview
Violations
Related Form 483s
Related Inspections
Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital
Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital, Number 10 and 12, Thillai Maistry Street Pondicherry 605001 Puducherry India
Issue Date
December 22, 2025
FEI Number
N/A
Violations
2
Country
India
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
In Vivo Bioavailability-Bioequivalence Studies – Clinical
Purushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital FDA Warning Letter, December 22, 2025
